Exabis Library
Welcome to the e-CCO Library!
DOP15 Transmural healing with vedolizumab in patients with active Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP15: Clinical relevance of endoscopic peri-appendiceal red patch in Ulcerative Colitis patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP15: Fluorescent labelled vedolizumab for real-time visualization and quantification of local drug distribution and pharmacodynamics in Inflammatory Bowel Diseases during endoscopy
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP15: Intestinal ultrasound correlates with colonoscopy and biomarkers, and can be used in a tight monitoring approach to assess response to therapy in Crohn's disease: a multicentre prospective study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP15: Metabolomics coupled with pathway analysis characterise metabolic changes in treatment-naive ulcerative colitis patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP16 An evaluation of the exposure–efficacy relationship for subcutaneous vedolizumab maintenance treatment of Crohn’s disease: Pharmacokinetic findings from VISIBLE 2
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP16: Anti-integrin ⍺vβ6 autoantibodies predate Ulcerative Colitis diagnosis by up to 10 years and are associated with adverse disease-related outcomes
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP16: Categorizing endoscopic severity of Crohn’s Disease using the Modified Multiplier SES-CD (MM-SES-CD)
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP16: Endoplasmic reticulum stress in subepithelial myofibroblasts increases the TGF-β1 activity that regulates fibrosis in Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP16: The ratio of submucosa thickness to the total bowel wall thickness can be a sonographic parameter to estimate endoscopic remission in Ulcerative Colitis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP17 Identification of biomarkers and mechanistic insight for upadacitinib in ulcerative colitis: Analysis of serum inflammatory mediators in the phase 2b U-ACHIEVE study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP17: AZD4205, a potent, GI tract-enriched, JAK1-selective inhibitor for treatment of inflammatory bowel disease (IBD)
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP17: Evaluating segmental healing with the modified Mayo endoscopic score (MMES) has a clear additional value in predicting long-term outcome in patients with Ulcerative Colitis: Results from a prospective cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP17: HIV infection is associated with a less aggressive phenotype of inflammatory bowel disease. A multicenter study based on the ENEIDA registry.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP17: In high-risk Crohn’s Disease patients, anastomosis configuration types have similar rates of endoscopic recurrence
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP18 Impact of adherence to anti-tumour necrosis factor therapy on clinical outcomes in Crohn’s disease: A nationwide population-based study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP18: Advanced optical diagnosis technology for assessment of endoscopic and histological remission in Ulcerative Colitis: A systematic review and meta-analysis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP18: Brain structural correlates of fatigue in active and quiescent Crohn's Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP18: OSM neutralisation in IBD mucosal explant cultures reduces pro-inflammatory cytokine production
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP18: UCEIS is associated with PRO2, partial Mayo and SCCAI remission in UC: Final results from a prospective study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM